Core Labs Reports Q1 GAAP Net Loss of $(0.02) EPS, Revenue Misses Estimates
CLB sits 49% above its 52-week low of $9.72.
Summary
Core Laboratories Inc. reported first-quarter 2026 GAAP diluted EPS of $(0.02) on revenue of $121.8 million. These results significantly missed analyst expectations of $0.11 EPS and $124.9 million revenue, and are notably worse than the adjusted EPS of $0.06 previously reported in an 8-K filing. The company cited operational headwinds including softer international lab demand, reduced field access, and pressured service margins due to elevated costs. This deeper loss and revenue miss indicate a challenging quarter for the company, highlighting the impact of market volatility and operational constraints. Traders will be watching for signs of stabilization in international demand and the performance of its energy-transition services.
At the time of this announcement, CLB was trading at $14.49 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $667.2M. The 52-week trading range was $9.72 to $20.36. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.